急性心肌缺血再灌注细胞凋亡与Carvedilol干预治疗

Myocardilol Apoptosis in the Process of Acute Myocardilol Ischemia-reperfusion and Carvedilol Treatment

急性心肌缺血再灌注过程中存在心肌细胞凋亡;认识和研究急性心肌缺血再灌注过程中心肌细胞凋亡的诱发因素及其基因表达与调控对防治急性心肌缺血再灌注损伤具有显示其临床应用价值。

Myocardilol apoptosis exists in acute myocardial ischemia-reperfusion. It is of great clinical value to recognize and study the inducing factors of myocardilol apoptosis and its genetic expression and regulation in the process of acute myocardial ischemia-reperfusion. It is also helpful to prevent and cure acute myocardial ischemia-reperfusion injury. Carvedilol has its distinctive pharmacologic activity. Animal experiments show its remarkable anti-apoptosis and its clinical practical value.